Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gejie Dingchuan Capsule is a traditional Chinese patent medicine (TCM) formulated as a capsule. Its primary active component is Tokay Gecko (*Gekko gecko*), known as 'Ge Jie', which is traditionally used to tonify the kidneys and lungs to relieve asthma. The formulation is a complex mixture including botanical and animal-derived ingredients such as Snakegourd Seed, Tatarian Aster Root, Ephedra, Turtle Shell, Baical Skullcap Root, Liquorice Root, Dwarf Lilyturf Tuber, Coptis chinensis, Lily Bulb, Perilla Fruit, Gypsum, and Bitter Apricot Seed. It is indicated for nourishing yin, clearing lung heat, and treating chronic respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). Clinical research, such as trial ChiCTR2300067958, has investigated its efficacy in patients with stable COPD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gejie dingchuan capsule.